Home > Find an expert

Prof. Yaakov Nahmias

Researcher interests: The development of microfabricated platforms for the study of liver biology, development, regeneration and metabolism. Investigation of the interactions between nuclear receptors and metabolic processes in the context of drug discovery, Hepatitis C Virus
DEPARTMENT: Bio-Engineering
Contact Business Development: Mel Larrosa
All projects by researcher: Novel Method to produces truly functional pluripotent stem cell-derived Hepatocytes. | NOVEL METHOD TO EXPAND AND GET HIGHER CONCENTRATION AND PROLIFERATION OF CHICKEN EMBRYONIC FIBROBLASTS CELLS | Tissue Dynamics | iCOUGH: Accumulative Breath Cougher for Spinal Cord Injuries | Future Meat Technologies LTD. | Device for Microwave Ablation of Small Tumors in the Digestive System
Stem cells (5)Microfluidics (2)Tissue Engineering (2)Liver (1)

Selected Publications

avner ehrlich, daniel duche, gladys ouedraogo, Yaakov Nahmias
challenges and opportunities in the design of liver on chip microdevices (2019)| | Read more
aaron cohen, alexander i alexandrov, ayelet chen abraham, daniel kaganovich, eliezer keinan, Merav Cohen, Yaakov Nahmias, Dana Reichmann, reshef mintz
high reynolds microfluidic sorting of large yeast populations (2018)| Scientific Reports| Read more
ariel shrem, elchanan fried, itai hayut, Yaakov Nahmias, tommy weisssadan
yonlendirmeli endotrakeal entubasyon sistemi (2018)| | Read more
Nir Friedman, jenia gutin, maya schuldiner, meytal radzinski, nadav shai, Yaakov Nahmias, Ohad Yogev, Tomer Ravid, Dana Reichmann, rosi fassler, sabina tsytkinkirschenzweig, sidra ilyas, William Breuer, yifat geffen
temporal profiling of redox dependent heterogeneity in single cells (2018)| eLife| Read more
Nir Friedman, jenia gutin, maya schuldiner, meytal radzinski, nadav shai, Yaakov Nahmias, Ohad Yogev, Tomer Ravid, Dana Reichmann, rosi fassler, sabina tsytkinkirschenzweig, sidra ilyas, William Breuer, yifat geffen
author response temporal profiling of redox dependent heterogeneity in single cells (2018)| | Read more
dorit avrahami, doron gerber, efrat barbiromichaely, Gahl Levy, michal pellach, Yaakov Nahmias, nika schwartz, reuven gil, Yair Glick
neuregulin 1 discovered as a cleavage target for the hcv ns3 4a protease by a microfluidic membrane protein array (2018)| New Biotechnology| Read more
Merav Cohen, Yaakov Nahmias, sabina tsytkinkirschenzweig
tracking glut2 translocation by live cell imaging (2018)| | Read more
anne riu, avner ehrlich, gladys ouedraogo, jan vanfleteren, konstantinos ioannidis, Merav Cohen, muneef ayyash, Yaakov Nahmias, sabina tsytkinkirschenzweig
microphysiological flux balance platform unravels the dynamics of drug induced steatosis (2018)| Lab on a Chip| Read more
adi drori, alina nemirovski, anna permyakova, asaad gammal, gil leibowitz, liad hinden, matan geron, Merav Cohen, Yaakov Nahmias, Avi Priel, Rivka Hadar, sabina tsytkinkirschenzweig, saja baraghithy, shiran udi, Joseph Tam, Yael Riahi
modulation of renal glut2 by the cannabinoid 1 receptor implications for the treatment of diabetic nephropathy (2017)| Journal of The American Society of Nephrology| Read more
avner elrich, elishai ezra tsur, idan maor, Michal Zimerman, Yaakov Nahmias
microfluidic concentric gradient generator design for high throughput cell based studies (2017)| Frontiers in Bioengineering and Biotechnology| Read more
ariel shochat, Amnon Buxboim, chanan vinitzky, Yaakov Nahmias, Ram Weiss, yaacov lacher
detection of peripheral arterial disease (2016)| | Read more
Ariel Drori, Bettina Nadorp, Amnon Buxboim, Chen Goldstein, liran levy, Yaakov Nahmias, yoav kantor
when every second counts novel device to shorten chest tube insertion time in a pre hospital setting (2016)| Pulmonary Therapy| Read more
Basak E Uygun, Daniel Kitsberg, david bomze, elishai ezra, ella h sklan, Nir Friedman, Gahl Levy, Naomi Habib, j timm, joerg f schlaak, korkut uygun, m trippler, maria angela guzzardi, Merav Cohen, Yaakov Nahmias, oren shibolet
nuclear receptors control pro viral and antiviral metabolic responses to hepatitis c virus infection (2016)| Nature Chemical Biology| Read more
Amnon Buxboim, Yaakov Nahmias, tal hasin, yoel goldstein
jugular venous assessment (2016)| | Read more
Daniel Kitsberg, Gahl Levy, joseph itskovitzeldor, Merav Cohen, Michal Zimerman, Arieh Moussaieff, Yaakov Nahmias, robert schwartz, ronen sadeh, Yishai Avior
microbial derived lithocholic acid and vitamin k2 drive the metabolic maturation of pluripotent stem cells derived and fetal hepatocytes (2015)| Hepatology| Read more
bohdana m rovenko, essi havula, mari teesalu, minna poukkula, mor hanan, Arieh Moussaieff, Yaakov Nahmias, osnat bartok, reut ashwallfluss, sadanand vodala, sebastian kadener, varun pandey, ville hietakangas
the transcription factor cabut coordinates energy metabolism and the circadian clock in response to sugar sensing (2015)| The EMBO Journal| Read more
alina nemirovski, benedicte elenaherrmann, daniel aberdam, Daniel Kitsberg, david bomze, dinorah barasch, eran meshorer, Gahl Levy, ilana laevsky, joseph itskovitzeldor, malka nissimrafinia, Matthieu Rouleau, Merav Cohen, michal amit, Arieh Moussaieff, Yaakov Nahmias, shai s shenorr, stefan kempa, tali scherf
glycolysis mediated changes in acetyl coa and histone acetylation control the early differentiation of embryonic stem cells (2015)| Cell Metabolism| Read more
Benjamin Aroeti, Daniel Kitsberg, Maria Shulman, Merav Cohen, Yaakov Nahmias, sabina tsytkin
live imaging of glut2 glucose dependent trafficking and its inhibition in polarized epithelial cysts (2014)| Open Biology| Read more

Success Stories & related Product & PR

Tyson Foods backs Israeli startup to grow meat in the lab

JERUSALEM (Reuters) - Tyson Foods (TSN.N), the largest U.S. meat processor, has invested in an Israeli biotech company developing a way to grow affordable meat in a laboratory that takes live animals out of the equation.

More

Tyson Ventures Announces Investment in Future Meat Technologies

JERUSALEM, ISRAEL – Future Meat Technologies has announced a $2.2 million seed investment round co-led by Tyson Ventures, the venture capital arm of Tyson Foods.  Tyson Foods is a Fortune 100 company, and one of the world’s largest food...

More

Contact for more information:

Mel Larrosa
VP Business Development Healthcare
+972-2-6586692
Contact ME: